Clover Health Investments Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-56.94	-85.55	-43.01	-213.36	-339.57	-587.76
Depreciation & Amortization	1.74	1.69	1.33	2.51	1.19	1.25
Stock-Based Compensation	89.49	103.66	114.33	140.93	164.31	163.72
Other Adjustments	-2.94	-2.53	-3.06	9.48	-128.17	58.45
Change in Receivables	-19.95	-43.33	12.63	6.44	-22.57	-24.38
Changes in Accounts Payable	8.62	1.65	-2.62	4.74	7.64	5.31
Changes in Accrued Expenses	0.71	-3.05	-1.97	-2.9	8.78	11.17
Changes in Other Operating Activities	36.51	-39.47	4.82	17.01	3.79	89.91
Operating Cash Flow	57.25	-66.93	34.85	-144.66	-203.93	-282.33
Capital Expenditures	-2.71	-2.04	-1.56	-0.58	-4.47	-0.72
Purchases of Investments	-212.84	-205.1	-201.24	-175.57	-369.4	-876.25
Proceeds from Sale of Investments	205.63	211.22	203.36	316.16	485.45	441.53
Payments for Business Acquisitions	-	-	-	-	-16.2	-
Other Investing Activities	-	-	-	-	-0.25	-
Investing Cash Flow	-9.92	4.08	0.57	140.01	95.13	-435.45
Long-Term Debt Repaid	-	-	-	-	-	-30.93
Net Long-Term Debt Issued (Repaid)	-	-	-	-	-	-30.93
Issuance of Common Stock	0.53	1.81	0.9	1.15	1.4	956.55
Repurchase of Common Stock	-31.14	-55.2	-18.26	-6.22	-6.36	-0.23
Net Common Stock Issued (Repurchased)	-30.6	-53.38	-17.36	-5.07	-4.96	956.32
Financing Cash Flow	-29.51	-53.38	-17.36	-5.07	-4.96	925.39
Net Cash Flow	129.58	-116.24	18.05	-9.72	-113.76	207.62
Free Cash Flow	54.54	-68.98	33.29	-145.25	-208.39	-283.05
FCF Margin	2.47%	-3.58%	2.43%	-11.52%	-19.00%	-19.23%
Free Cash Flow Per Share	0.11	-0.13	0.07	-0.30	-0.44	-0.69
Levered Free Cash Flow	34.28	-126.78	-43	-192.59	-322.64	-511.77
Unlevered Free Cash Flow	72.19	-126.76	-45.74	-184.56	-269.74	-530.08

SEC Filings: 10-K · 10-Q